Flowr logo

FLWR - Flowr News Story

C$0.27 0.0  0.0%

Last Trade - 07/05/21

Small Cap
Market Cap £54.0m
Enterprise Value £85.6m
Revenue £4.43m
Position in Universe 911th / 2702

Flowr and Hawthorne Canada Jointly Announce the Completion of the World’s First Cannabis Research and Development Facility of its Kind

Tue 5th January, 2021 1:00pm
For best results when printing this announcement, please click on link below:

America’s first research and development facility dedicated to advancing
cannabis cultivation techniques and systems has been completed by The Flowr
Corporation (TSXV: FLWR) and Hawthorne Canada Limited (“Hawthorne”).
Hawthorne is a subsidiary of the Hawthorne Gardening Company division of The
Scotts Miracle-Gro Company (NYSE:SMG). Scotts Miracle-Gro is the world’s
leading marketer of branded consumer lawn and garden products and indoor
growing solutions. Flowr cultivates and sells premium cannabis to medical and
adult-use markets in Canada, Europe and Australia.

Located on Flowr’s cultivation campus in Kelowna, British Columbia, Canada,
the R&D Center includes state-of-the-art laboratories, indoor grow suites, and
training areas in a single building. Flowr will test cultivation systems and
techniques using Hawthorne’s advanced lighting, fertilization and irrigation
systems, growing mediums, and research protocols. In addition, Flowr intends
to focus its own research on cannabis genetics and integrated growing systems
in line with its goal of delivering premium quality cannabis products through
highly efficient cultivation.

“We built Hawthorne to help cultivators of all sizes grow quality plants
with high levels of efficiency and consistency. Completing the industry’s
only dedicated R&D facility gives us a distinct advantage. We will leverage
Flowr’s cultivation expertise and our technical capabilities into real world
testing and results that will make a difference to growers,” said Chris
Hagedorn, SVP & General Manager of Hawthorne Gardening. “We are proud of
this collaboration with Flowr, a leading international cannabis company, with
extensive growing experience indoors, in greenhouses and at-scale outdoors.
Flowr is also one of a few companies that have had experience growing diverse
genetics in different countries. We believe this experience will benefit our
companies and the growers we serve.”

“The completion of the R&D Center brings our work with Hawthorne fully to
life and will help keep both companies on the leading edge of cannabis
cultivation for years to come,” commented Lance Emanuel, President and
Interim Chief Executive Officer of Flowr. “Operationalizing the R&D Center
is a major accomplishment for our organization and strengthens our
competitive advantage in cultivation. We believe the long-term success of
Flowr will be rooted in our ability to maximize the cannabinoid and terpene
expression of genetics without sacrificing yield. The work we will do at the
R&D Center will help us build upon the success we’ve had producing high
quality, premium cannabis like our award-winning, flagship-strain BC Pink
Kush beloved by budtenders and consumers throughout Canada. Leveraging our
work at the R&D Center will be imperative to our eventual entry into the
United States once federally permissible by law.”

The R&D Center is the centerpiece of a strategic R&D partnership formed by
Flowr and Hawthorne in March 2018. It brings two of the world’s leading
experts together to be at the forefront of cannabis cultivation. The
operations will be led by Dr. Deron Caplan, the first person in North America
to earn a PhD focused on cannabis cultivation and production. Dr. Caplan was
awarded his doctorate by the University of Guelph in August 2018 and is
Flowr’s Director of Research and Development. The R&D Center will be staffed
by Flowr’s scientists, five of whom have PhDs in various plant biology,
plant genetics and plant biochemistry disciplines. Hawthorne R&D will lead the
research design and methodology.

All requisite licensing from Health Canada has been obtained by Flowr and the
expectation is that the R&D Center will be operating at full capacity in
Spring 2021. Research has already begun conducting growing trials at scale
using Hawthorne products.

About Hawthorne Gardening Company

We know why you grow. And that influences everything we do. We are a company
guided by a set of principles that motivate us every day. Hawthorne Gardening
Company is built to serve growers of all sizes, from commercial cultivators to
home hobbyists. We are made up of dozens of best-in-class brands, from Gavita,
General Hydroponics and Sun System, to Botanicare and Mother Earth, that span
every growing category from lighting to nutrients, growing environment,
growing media, hardware, and many more. We drive bold research and development
investments, unparalleled distribution capabilities and extensive service
solutions that go far beyond product. And we use our voice to advance
legislation that supports the responsible legalization of cannabis. Because
our goal is to enable all growers to seize today's unprecedented opportunities
and build the industry of tomorrow. Learn more at www.hawthorne-gardening.com.

About The Flowr Corporation

The Flowr Corporation is a Toronto-headquartered cannabis company with
operations in Canada, Europe, and Australia. Its Canadian operating campus,
located in Kelowna, BC, includes a purpose-built, GMP-designed indoor
cultivation facility, an outdoor and greenhouse cultivation site, and a
state-of-the-art R&D facility. From this campus, Flowr produces recreational
and medicinal products. Internationally, Flowr intends to service the global
medical cannabis market through its subsidiary Holigen, which has a license
for cannabis cultivation in Portugal and operates GMP licensed facilities in
both Portugal and Australia.

Flowr aims to support improving outcomes through responsible cannabis use and,
as an established expert in cannabis cultivation, strives to be the brand of
choice for consumers and patients seeking the highest-quality craftsmanship
and product consistency across a portfolio of differentiated cannabis

For more information, please visit flowrco
or follow Flowr on Twitter: @FlowrCanada and LinkedIn: The Flowr Corporation.

Forward-Looking Information and Statements

This press release contains “forward-looking information” within the
meaning of Canadian securities laws, which may include but is not limited to
statements made concerning: the planned testing of cultivation systems and
techniques using Hawthorne’s advanced lighting, fertilization and irrigation
systems, growing mediums and research protocols; Flowr focusing its own
research on cannabis plant genetics and integrated growing systems and its
goals of such research; and the impact of the center and the activities to be
conducted on the long-term success of Flowr. Often, but not always,
forward-looking information can be identified by the use of words such as
“plans”, “is expected”, “expects”, “scheduled”, “intends”,
“contemplates”, “anticipates”, “believes”, “proposes'' or
variations (including negative and grammatical variations) of such words and
phrases, or state that certain actions, events or results “may”,
“could”, “would”, “might” or “will” be taken, occur or be
achieved. Such information and statements are based on the current
expectations of Flowr’s management and are based on assumptions and subject
to risks and uncertainties. Although Flowr’s management believes that the
assumptions underlying such information and statements are reasonable, they
may prove to be incorrect. The forward-looking events and circumstances
discussed in this press release may not occur by certain specified dates or at
all and could differ materially as a result of known and unknown risk factors
and uncertainties affecting Flowr, including risks relating to: the proposed
completion of the Arrangement with Terrace Global; general economic and stock
market conditions; adverse industry events; loss of markets; future
legislative and regulatory developments in Canada and elsewhere; the cannabis
industry in Canada generally; the ability of Flowr to implement its business
strategies; the inability to grow cannabis at a low cost or with the desired
THC levels; Flowr’s inability to produce or sell premium quality cannabis,
risks and uncertainties detailed from time to time in Flowr’s filings with
the Canadian Securities Administrators; the Company’s inability to raise
capital or have the liquidity to operate or advance its strategic initiatives
and many other factors beyond the control of Flowr.

Although Flowr has attempted to identify important factors that could cause
actual actions, events or results to differ materially from those described in
forward-looking information or statements, there may be other factors that
cause actions, events or results to differ from those anticipated, estimated
or intended. No forward-looking information or statement can be guaranteed.
Except as required by applicable securities laws, forward-looking information
and statements speak only as of the date on which they are made and Flowr
undertakes no obligation to publicly update or revise any forward-looking
information or statements, whether as a result of new information, future
events or otherwise. When considering such forward-looking information and
statements, readers should keep in mind the risk factors and other cautionary
statements in Flowr’s Annual Information Form dated April 29, 2020 (the
“AIF”) and filed with the applicable securities regulatory authorities in
Canada. The risk factors and other factors noted in the AIF could cause actual
events or results to differ materially from those described in any
forward-looking information or statements.


For Flowr
Thierry Elmaleh
Head of Capital Markets
(877) 356-9726 ext. 1528

For Hawthorne Canada
Molly Jennings
Public Affairs 

A photo accompanying this announcement is available at

The Hawthorne R&D Center 
The Hawthorne R&D Center, from Flowr’s Kelowna Campus in British Columbia.

GlobeNewswire, Inc. 2021
© Stockopedia 2021, Refinitiv, Share Data Services.
This site cannot substitute for professional investment advice or independent factual verification. To use it, you must accept our Terms of Use, Privacy and Disclaimer policies.